GLP-1 Agonists NJ: Why Tirzepatide Is a Game Changer in 2025
The Evolution of GLP-1 Agonists and Their Impact on Obesity Medicine in New Jersey As obesity continues to be a critical public health challenge in New Jersey, the advent of advanced pharmacotherapies has reshaped treatment paradigms. Among these, GLP-1 agonists have emerged as a cornerstone in medically supervised weight loss programs. Tirzepatide, a novel dual … Read more